Nichole Reisdorph
Concepts (615)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Metabolomics | 24 | 2023 | 521 | 4.790 |
Why?
| Metabolome | 12 | 2023 | 282 | 2.280 |
Why?
| Mass Spectrometry | 22 | 2021 | 633 | 2.250 |
Why?
| Tandem Mass Spectrometry | 10 | 2023 | 411 | 2.060 |
Why?
| Proteomics | 12 | 2019 | 836 | 1.480 |
Why?
| Bronchoalveolar Lavage Fluid | 8 | 2018 | 590 | 1.440 |
Why?
| Ion Mobility Spectrometry | 3 | 2020 | 5 | 1.430 |
Why?
| Proteome | 8 | 2019 | 339 | 1.360 |
Why?
| Lipids | 6 | 2022 | 580 | 1.270 |
Why?
| Chromatography, High Pressure Liquid | 10 | 2020 | 470 | 1.230 |
Why?
| Asthma | 11 | 2022 | 2029 | 1.190 |
Why?
| Biomarkers | 24 | 2023 | 3408 | 0.960 |
Why?
| Research | 2 | 2018 | 394 | 0.940 |
Why?
| Amino Acids | 4 | 2020 | 448 | 0.910 |
Why?
| Diet, Mediterranean | 1 | 2023 | 20 | 0.880 |
Why?
| Chromatography, Liquid | 10 | 2023 | 347 | 0.860 |
Why?
| Lung | 10 | 2022 | 3559 | 0.810 |
Why?
| Eicosanoids | 4 | 2022 | 54 | 0.810 |
Why?
| Blood Chemical Analysis | 3 | 2014 | 90 | 0.790 |
Why?
| Pulmonary Disease, Chronic Obstructive | 7 | 2022 | 913 | 0.780 |
Why?
| Metabolic Networks and Pathways | 5 | 2021 | 168 | 0.780 |
Why?
| Benz(a)Anthracenes | 1 | 2021 | 2 | 0.750 |
Why?
| Benzopyrenes | 1 | 2021 | 4 | 0.750 |
Why?
| Polycyclic Aromatic Hydrocarbons | 1 | 2021 | 24 | 0.730 |
Why?
| Liquid-Liquid Extraction | 3 | 2018 | 15 | 0.700 |
Why?
| Dietary Approaches To Stop Hypertension | 1 | 2020 | 10 | 0.680 |
Why?
| Ozone | 4 | 2022 | 99 | 0.680 |
Why?
| Animals | 53 | 2023 | 31698 | 0.660 |
Why?
| Breath Tests | 2 | 2017 | 82 | 0.660 |
Why?
| Food | 2 | 2020 | 160 | 0.650 |
Why?
| Mice | 37 | 2023 | 14863 | 0.630 |
Why?
| Organic Chemicals | 1 | 2020 | 112 | 0.630 |
Why?
| Phosphopeptides | 1 | 2018 | 15 | 0.620 |
Why?
| Peptide Mapping | 1 | 2018 | 60 | 0.620 |
Why?
| Databases, Chemical | 1 | 2018 | 6 | 0.610 |
Why?
| Monocytes | 1 | 2021 | 502 | 0.600 |
Why?
| Cardiovascular Diseases | 3 | 2023 | 1727 | 0.600 |
Why?
| Isotope Labeling | 1 | 2018 | 69 | 0.590 |
Why?
| Tyrosine | 1 | 2018 | 214 | 0.580 |
Why?
| Skin | 3 | 2018 | 655 | 0.570 |
Why?
| Pulmonary Emphysema | 4 | 2019 | 268 | 0.550 |
Why?
| Macrophages | 2 | 2021 | 1261 | 0.550 |
Why?
| Smoking | 7 | 2020 | 1381 | 0.550 |
Why?
| Tobacco Smoke Pollution | 2 | 2017 | 217 | 0.550 |
Why?
| Hypersensitivity | 4 | 2022 | 252 | 0.550 |
Why?
| Adaptor Proteins, Signal Transducing | 3 | 2018 | 367 | 0.540 |
Why?
| Plasma | 2 | 2017 | 211 | 0.530 |
Why?
| Humans | 69 | 2023 | 114654 | 0.530 |
Why?
| Saliva | 1 | 2017 | 187 | 0.510 |
Why?
| Computational Biology | 3 | 2020 | 530 | 0.500 |
Why?
| Gas Chromatography-Mass Spectrometry | 2 | 2020 | 124 | 0.500 |
Why?
| Glycerophospholipids | 4 | 2022 | 26 | 0.490 |
Why?
| Mitochondria | 5 | 2023 | 747 | 0.490 |
Why?
| Peptides | 4 | 2019 | 848 | 0.490 |
Why?
| Nerve Tissue Proteins | 1 | 2018 | 529 | 0.470 |
Why?
| Cell Differentiation | 2 | 2021 | 1700 | 0.460 |
Why?
| Alveolar Epithelial Cells | 3 | 2019 | 93 | 0.460 |
Why?
| Leukotriene E4 | 3 | 2013 | 27 | 0.450 |
Why?
| Microbiota | 4 | 2022 | 647 | 0.430 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 2 | 2020 | 162 | 0.430 |
Why?
| Chromatography, Reverse-Phase | 1 | 2013 | 26 | 0.430 |
Why?
| Software | 4 | 2020 | 530 | 0.420 |
Why?
| Bronchoalveolar Lavage | 3 | 2018 | 84 | 0.400 |
Why?
| Endocannabinoids | 2 | 2022 | 36 | 0.400 |
Why?
| Liver | 4 | 2020 | 1637 | 0.390 |
Why?
| Sirtuin 3 | 3 | 2023 | 52 | 0.390 |
Why?
| Autoantigens | 4 | 2019 | 396 | 0.390 |
Why?
| Reproducibility of Results | 7 | 2020 | 2762 | 0.380 |
Why?
| Eicosapentaenoic Acid | 2 | 2021 | 28 | 0.370 |
Why?
| Transcriptome | 4 | 2022 | 725 | 0.360 |
Why?
| Cholesterol | 2 | 2023 | 367 | 0.350 |
Why?
| Fatty Acids, Omega-3 | 2 | 2022 | 122 | 0.350 |
Why?
| Male | 40 | 2023 | 55579 | 0.350 |
Why?
| Sleep Deprivation | 2 | 2023 | 166 | 0.340 |
Why?
| Immunoenzyme Techniques | 1 | 2009 | 192 | 0.320 |
Why?
| Species Specificity | 2 | 2020 | 542 | 0.320 |
Why?
| Mice, Inbred C57BL | 9 | 2022 | 4692 | 0.320 |
Why?
| Analgesia | 1 | 2010 | 82 | 0.320 |
Why?
| Middle Aged | 19 | 2023 | 26732 | 0.300 |
Why?
| Workflow | 2 | 2020 | 133 | 0.300 |
Why?
| Sensitivity and Specificity | 5 | 2017 | 1691 | 0.300 |
Why?
| Female | 36 | 2023 | 59488 | 0.290 |
Why?
| Kainic Acid | 2 | 2018 | 31 | 0.290 |
Why?
| Urinalysis | 2 | 2020 | 64 | 0.280 |
Why?
| Blood Pressure | 4 | 2020 | 1538 | 0.280 |
Why?
| Mitochondrial Proteins | 2 | 2019 | 219 | 0.280 |
Why?
| Chromatography, Ion Exchange | 1 | 2007 | 48 | 0.280 |
Why?
| Inflammation Mediators | 2 | 2020 | 477 | 0.270 |
Why?
| Obesity | 6 | 2022 | 2508 | 0.270 |
Why?
| Diet | 3 | 2023 | 1080 | 0.270 |
Why?
| Disease Models, Animal | 8 | 2021 | 3531 | 0.260 |
Why?
| Data Interpretation, Statistical | 2 | 2018 | 321 | 0.260 |
Why?
| Fetal Growth Retardation | 2 | 2021 | 467 | 0.260 |
Why?
| Diet, High-Fat | 3 | 2022 | 225 | 0.260 |
Why?
| Body Fluids | 2 | 2017 | 58 | 0.250 |
Why?
| Dermatitis, Atopic | 3 | 2018 | 307 | 0.250 |
Why?
| Sleep | 4 | 2023 | 631 | 0.250 |
Why?
| Receptors, G-Protein-Coupled | 3 | 2021 | 194 | 0.250 |
Why?
| Sodium Nitrite | 2 | 2015 | 37 | 0.250 |
Why?
| Pulmonary Medicine | 1 | 2006 | 87 | 0.250 |
Why?
| Pilot Projects | 6 | 2022 | 1373 | 0.240 |
Why?
| CD4-Positive T-Lymphocytes | 3 | 2016 | 959 | 0.240 |
Why?
| Ethanol | 2 | 2019 | 538 | 0.240 |
Why?
| Docosahexaenoic Acids | 3 | 2021 | 69 | 0.230 |
Why?
| Flavoproteins | 1 | 2004 | 7 | 0.230 |
Why?
| Photoreceptor Cells, Invertebrate | 1 | 2004 | 3 | 0.230 |
Why?
| Chlamydomonas reinhardtii | 1 | 2004 | 5 | 0.230 |
Why?
| Pneumonia | 2 | 2021 | 567 | 0.230 |
Why?
| Dietary Supplements | 4 | 2022 | 460 | 0.230 |
Why?
| Fatty Acids, Unsaturated | 2 | 2022 | 84 | 0.230 |
Why?
| Agaricus | 1 | 2023 | 2 | 0.230 |
Why?
| Salmon | 1 | 2023 | 12 | 0.220 |
Why?
| Solid Phase Extraction | 2 | 2014 | 20 | 0.220 |
Why?
| Eye Proteins | 1 | 2004 | 70 | 0.220 |
Why?
| Proteins | 3 | 2017 | 908 | 0.220 |
Why?
| Seafood | 1 | 2023 | 16 | 0.220 |
Why?
| Islet Amyloid Polypeptide | 2 | 2016 | 47 | 0.220 |
Why?
| Oxadiazoles | 1 | 2003 | 32 | 0.220 |
Why?
| Rhinovirus | 1 | 2003 | 40 | 0.220 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2020 | 134 | 0.220 |
Why?
| Isoxazoles | 1 | 2003 | 51 | 0.220 |
Why?
| Immunoglobulin Fab Fragments | 1 | 2003 | 69 | 0.210 |
Why?
| Capsid | 1 | 2003 | 75 | 0.210 |
Why?
| Hippocampus | 2 | 2018 | 693 | 0.210 |
Why?
| Arachidonic Acids | 1 | 2022 | 56 | 0.210 |
Why?
| Oxidative Stress | 4 | 2021 | 1076 | 0.210 |
Why?
| Drosophila Proteins | 1 | 2004 | 164 | 0.200 |
Why?
| Acylation | 2 | 2019 | 28 | 0.200 |
Why?
| Prostaglandins | 2 | 2022 | 77 | 0.200 |
Why?
| Cell Line | 6 | 2019 | 2635 | 0.200 |
Why?
| Myocardium | 3 | 2019 | 913 | 0.200 |
Why?
| Cells, Cultured | 6 | 2021 | 3885 | 0.200 |
Why?
| Insulin-Secreting Cells | 3 | 2020 | 317 | 0.200 |
Why?
| Linear Models | 2 | 2018 | 768 | 0.200 |
Why?
| Lipoxins | 1 | 2021 | 10 | 0.200 |
Why?
| Mice, Knockout | 9 | 2021 | 2568 | 0.190 |
Why?
| NAD(P)H Dehydrogenase (Quinone) | 2 | 2020 | 31 | 0.190 |
Why?
| Citrate (si)-Synthase | 1 | 2021 | 46 | 0.190 |
Why?
| Sepsis | 1 | 2007 | 509 | 0.190 |
Why?
| Liver Diseases, Alcoholic | 2 | 2019 | 81 | 0.190 |
Why?
| Quantitative Trait Loci | 2 | 2021 | 305 | 0.190 |
Why?
| Bacterial Toxins | 1 | 2022 | 103 | 0.190 |
Why?
| Dinoprostone | 1 | 2022 | 184 | 0.190 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2022 | 139 | 0.190 |
Why?
| Brain Chemistry | 1 | 2021 | 115 | 0.190 |
Why?
| Lipid Metabolism | 3 | 2018 | 444 | 0.190 |
Why?
| Calcifediol | 2 | 2022 | 29 | 0.190 |
Why?
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2021 | 20 | 0.190 |
Why?
| Receptors, Scavenger | 1 | 2021 | 16 | 0.190 |
Why?
| Amidohydrolases | 1 | 2021 | 28 | 0.180 |
Why?
| Sleep Disorders, Circadian Rhythm | 1 | 2021 | 37 | 0.180 |
Why?
| Neuroprotection | 1 | 2021 | 30 | 0.180 |
Why?
| Leukocytes, Mononuclear | 4 | 2022 | 493 | 0.180 |
Why?
| Vitamin D Deficiency | 1 | 2022 | 158 | 0.180 |
Why?
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2020 | 24 | 0.180 |
Why?
| Aged | 11 | 2023 | 19068 | 0.180 |
Why?
| Melatonin | 1 | 2021 | 105 | 0.180 |
Why?
| Fatty Acids, Omega-6 | 1 | 2020 | 45 | 0.180 |
Why?
| Insulin | 3 | 2022 | 2078 | 0.180 |
Why?
| Cross-Over Studies | 2 | 2020 | 440 | 0.180 |
Why?
| Bariatric Surgery | 1 | 2022 | 161 | 0.170 |
Why?
| Vital Capacity | 2 | 2018 | 255 | 0.170 |
Why?
| Nasal Polyps | 1 | 2020 | 49 | 0.170 |
Why?
| Phosphorylation | 4 | 2019 | 1569 | 0.170 |
Why?
| Anti-Citrullinated Protein Antibodies | 1 | 2021 | 90 | 0.170 |
Why?
| Neuroprotective Agents | 1 | 2021 | 104 | 0.170 |
Why?
| Phosphatidylcholines | 1 | 2020 | 133 | 0.170 |
Why?
| Lung Injury | 1 | 2022 | 197 | 0.170 |
Why?
| Vesicular Transport Proteins | 1 | 2020 | 83 | 0.170 |
Why?
| Biotransformation | 1 | 2020 | 48 | 0.170 |
Why?
| Tubulin | 1 | 2020 | 123 | 0.170 |
Why?
| Protein Deglycase DJ-1 | 1 | 2019 | 6 | 0.170 |
Why?
| Aging | 3 | 2023 | 1618 | 0.170 |
Why?
| Umbilical Arteries | 1 | 2020 | 41 | 0.170 |
Why?
| Succinic Acid | 1 | 2019 | 44 | 0.170 |
Why?
| Liposomes | 1 | 2020 | 146 | 0.170 |
Why?
| Vitamins | 1 | 2021 | 151 | 0.170 |
Why?
| Myofibrils | 1 | 2019 | 46 | 0.170 |
Why?
| Islets of Langerhans | 2 | 2019 | 726 | 0.170 |
Why?
| Neurodegenerative Diseases | 1 | 2021 | 92 | 0.170 |
Why?
| Uterine Artery | 1 | 2020 | 67 | 0.160 |
Why?
| Hyperinsulinism | 1 | 2020 | 103 | 0.160 |
Why?
| Epithelium | 1 | 2020 | 295 | 0.160 |
Why?
| Synapses | 1 | 2022 | 330 | 0.160 |
Why?
| Anthracenes | 1 | 2019 | 27 | 0.160 |
Why?
| Rhinitis | 1 | 2020 | 128 | 0.160 |
Why?
| DNA End-Joining Repair | 1 | 2019 | 15 | 0.160 |
Why?
| Inhalation Exposure | 2 | 2021 | 97 | 0.160 |
Why?
| Adult | 14 | 2023 | 30542 | 0.160 |
Why?
| Fluorenes | 1 | 2019 | 38 | 0.160 |
Why?
| Dietary Proteins | 1 | 2020 | 122 | 0.160 |
Why?
| Spleen | 1 | 2020 | 487 | 0.160 |
Why?
| C-Peptide | 2 | 2016 | 138 | 0.160 |
Why?
| Single-Cell Analysis | 1 | 2020 | 188 | 0.160 |
Why?
| Sinusitis | 1 | 2020 | 174 | 0.150 |
Why?
| Microtubules | 1 | 2020 | 237 | 0.150 |
Why?
| Trypsin | 1 | 2018 | 66 | 0.150 |
Why?
| Cysteine | 1 | 2019 | 171 | 0.150 |
Why?
| Excitatory Amino Acid Agonists | 1 | 2018 | 37 | 0.150 |
Why?
| Gene Expression | 4 | 2020 | 1421 | 0.150 |
Why?
| B-Lymphocyte Subsets | 1 | 2018 | 68 | 0.150 |
Why?
| Leukotrienes | 1 | 2018 | 35 | 0.150 |
Why?
| Epilepsy, Temporal Lobe | 1 | 2018 | 20 | 0.150 |
Why?
| Myocardial Ischemia | 1 | 2019 | 235 | 0.150 |
Why?
| Limit of Detection | 1 | 2018 | 53 | 0.150 |
Why?
| Diet, Ketogenic | 1 | 2018 | 33 | 0.150 |
Why?
| NAD | 1 | 2018 | 63 | 0.150 |
Why?
| Niacinamide | 1 | 2018 | 63 | 0.150 |
Why?
| Flow Injection Analysis | 1 | 2017 | 5 | 0.140 |
Why?
| Kynurenine | 1 | 2018 | 81 | 0.140 |
Why?
| Fatty Acids, Essential | 1 | 2017 | 3 | 0.140 |
Why?
| Adiponectin | 2 | 2022 | 213 | 0.140 |
Why?
| Interleukin-6 | 2 | 2021 | 676 | 0.140 |
Why?
| Inflammasomes | 1 | 2018 | 115 | 0.140 |
Why?
| Influenza, Human | 1 | 2022 | 546 | 0.140 |
Why?
| Sample Size | 1 | 2017 | 112 | 0.140 |
Why?
| Health | 1 | 2017 | 74 | 0.140 |
Why?
| Immunophenotyping | 2 | 2018 | 274 | 0.140 |
Why?
| Hydrolases | 1 | 2017 | 51 | 0.140 |
Why?
| Hyperglycemia | 1 | 2020 | 291 | 0.140 |
Why?
| Autoimmunity | 2 | 2021 | 813 | 0.140 |
Why?
| Nerve Growth Factors | 1 | 2017 | 71 | 0.140 |
Why?
| Orthomyxoviridae Infections | 1 | 2017 | 54 | 0.140 |
Why?
| Sex Characteristics | 1 | 2021 | 640 | 0.140 |
Why?
| Proline | 1 | 2017 | 72 | 0.140 |
Why?
| Antibodies | 1 | 2018 | 371 | 0.140 |
Why?
| Sphingolipids | 1 | 2017 | 57 | 0.140 |
Why?
| Disease | 1 | 2017 | 85 | 0.140 |
Why?
| Artifacts | 1 | 2017 | 114 | 0.140 |
Why?
| Actins | 1 | 2018 | 381 | 0.130 |
Why?
| Cardiomyopathies | 1 | 2019 | 298 | 0.130 |
Why?
| Signal Transduction | 4 | 2022 | 4512 | 0.130 |
Why?
| High-Throughput Screening Assays | 1 | 2017 | 123 | 0.130 |
Why?
| Immunity, Humoral | 1 | 2017 | 112 | 0.130 |
Why?
| HEK293 Cells | 1 | 2018 | 591 | 0.130 |
Why?
| Vascular Stiffness | 2 | 2018 | 407 | 0.130 |
Why?
| Epitopes | 2 | 2016 | 435 | 0.130 |
Why?
| Acetylation | 3 | 2023 | 211 | 0.130 |
Why?
| Emphysema | 2 | 2013 | 107 | 0.130 |
Why?
| Arginine | 1 | 2017 | 238 | 0.130 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 3 | 2011 | 100 | 0.130 |
Why?
| Brain | 2 | 2018 | 2371 | 0.130 |
Why?
| Apoptosis | 4 | 2017 | 2362 | 0.130 |
Why?
| Epitopes, T-Lymphocyte | 1 | 2016 | 170 | 0.130 |
Why?
| Metabolic Syndrome | 1 | 2018 | 321 | 0.120 |
Why?
| Amino Acid Sequence | 5 | 2016 | 1982 | 0.120 |
Why?
| Endoplasmic Reticulum | 1 | 2017 | 234 | 0.120 |
Why?
| Aorta | 2 | 2015 | 386 | 0.120 |
Why?
| Glycosphingolipids | 1 | 2015 | 8 | 0.120 |
Why?
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2015 | 37 | 0.120 |
Why?
| Electrophysiology | 1 | 2015 | 201 | 0.120 |
Why?
| Forensic Sciences | 1 | 2014 | 6 | 0.120 |
Why?
| Chlorine | 1 | 2015 | 62 | 0.120 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2016 | 160 | 0.120 |
Why?
| Patch-Clamp Techniques | 1 | 2015 | 239 | 0.120 |
Why?
| Insulin Resistance | 1 | 2022 | 1072 | 0.120 |
Why?
| Carotid Arteries | 1 | 2015 | 180 | 0.120 |
Why?
| Diabetes Mellitus, Type 1 | 4 | 2019 | 3252 | 0.110 |
Why?
| Cerebrospinal Fluid | 1 | 2014 | 90 | 0.110 |
Why?
| Interleukin-16 | 1 | 2013 | 6 | 0.110 |
Why?
| Lung Diseases | 2 | 2013 | 701 | 0.110 |
Why?
| Gangliosides | 1 | 2013 | 18 | 0.110 |
Why?
| Leukotriene Antagonists | 1 | 2013 | 41 | 0.110 |
Why?
| Health Status | 1 | 2018 | 722 | 0.110 |
Why?
| Methyl Ethers | 1 | 2013 | 7 | 0.110 |
Why?
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2013 | 14 | 0.110 |
Why?
| Case-Control Studies | 2 | 2018 | 3003 | 0.110 |
Why?
| Alcohol Drinking | 1 | 2019 | 651 | 0.110 |
Why?
| Up-Regulation | 2 | 2019 | 807 | 0.110 |
Why?
| Smoking Cessation | 1 | 2017 | 374 | 0.110 |
Why?
| Methanol | 1 | 2013 | 29 | 0.110 |
Why?
| Education | 1 | 2013 | 95 | 0.110 |
Why?
| Adrenergic beta-Agonists | 1 | 2013 | 126 | 0.100 |
Why?
| Arthritis, Rheumatoid | 1 | 2021 | 1003 | 0.100 |
Why?
| Epilepsy | 1 | 2016 | 277 | 0.100 |
Why?
| Muscle, Skeletal | 1 | 2021 | 1472 | 0.100 |
Why?
| Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 176 | 0.100 |
Why?
| B-Lymphocytes | 1 | 2017 | 766 | 0.100 |
Why?
| Oxidation-Reduction | 3 | 2020 | 923 | 0.100 |
Why?
| Aged, 80 and over | 3 | 2018 | 6345 | 0.100 |
Why?
| Mice, Inbred NOD | 4 | 2016 | 555 | 0.100 |
Why?
| Hydroxyeicosatetraenoic Acids | 2 | 2022 | 40 | 0.100 |
Why?
| Bronchodilator Agents | 1 | 2013 | 239 | 0.100 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2013 | 238 | 0.100 |
Why?
| Heart Diseases | 1 | 2015 | 331 | 0.100 |
Why?
| Fatty Acids | 3 | 2018 | 381 | 0.090 |
Why?
| Calcium | 1 | 2017 | 1108 | 0.090 |
Why?
| Molecular Sequence Data | 4 | 2016 | 2785 | 0.090 |
Why?
| Ovarian Follicle | 1 | 2011 | 61 | 0.090 |
Why?
| fas Receptor | 1 | 2011 | 91 | 0.090 |
Why?
| Kaposi Varicelliform Eruption | 1 | 2011 | 22 | 0.090 |
Why?
| Motor Activity | 1 | 2015 | 640 | 0.090 |
Why?
| Rats | 4 | 2022 | 4958 | 0.090 |
Why?
| Electrophoresis, Polyacrylamide Gel | 2 | 2018 | 318 | 0.090 |
Why?
| Pneumonia, Mycoplasma | 1 | 2010 | 30 | 0.090 |
Why?
| Aluminum | 1 | 2010 | 34 | 0.090 |
Why?
| Mice, Obese | 2 | 2021 | 53 | 0.090 |
Why?
| Dietary Fats | 2 | 2022 | 287 | 0.090 |
Why?
| Light | 2 | 2021 | 336 | 0.090 |
Why?
| Gene Expression Regulation | 3 | 2015 | 2319 | 0.090 |
Why?
| Toll-Like Receptor 2 | 1 | 2010 | 110 | 0.090 |
Why?
| Ovary | 1 | 2011 | 191 | 0.080 |
Why?
| Sarcomeres | 1 | 2010 | 90 | 0.080 |
Why?
| E2F2 Transcription Factor | 1 | 2009 | 15 | 0.080 |
Why?
| Anti-Asthmatic Agents | 1 | 2013 | 349 | 0.080 |
Why?
| Phosphopyruvate Hydratase | 1 | 2009 | 30 | 0.080 |
Why?
| Chromogranin A | 1 | 2010 | 39 | 0.080 |
Why?
| Lymphocyte Activation | 3 | 2018 | 1037 | 0.080 |
Why?
| Endothelium, Vascular | 1 | 2015 | 847 | 0.080 |
Why?
| Fatty Acid-Binding Proteins | 1 | 2009 | 60 | 0.080 |
Why?
| Adjuvants, Immunologic | 1 | 2010 | 206 | 0.080 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2022 | 2094 | 0.080 |
Why?
| Binding Sites | 2 | 2020 | 1168 | 0.080 |
Why?
| Protein C | 1 | 2009 | 45 | 0.080 |
Why?
| RNA, Ribosomal, 16S | 2 | 2022 | 485 | 0.080 |
Why?
| Glycoproteins | 1 | 2010 | 304 | 0.080 |
Why?
| Phosphoproteins | 1 | 2010 | 298 | 0.080 |
Why?
| Reactive Oxygen Species | 2 | 2023 | 531 | 0.080 |
Why?
| Cognition | 1 | 2015 | 989 | 0.080 |
Why?
| Respiratory Mucosa | 1 | 2010 | 251 | 0.080 |
Why?
| Muscle Proteins | 1 | 2010 | 210 | 0.080 |
Why?
| Sirtuins | 2 | 2019 | 32 | 0.080 |
Why?
| Sphingomyelins | 2 | 2020 | 26 | 0.080 |
Why?
| Vasoconstriction | 1 | 2009 | 177 | 0.080 |
Why?
| Group IV Phospholipases A2 | 2 | 2019 | 45 | 0.080 |
Why?
| Exercise | 1 | 2018 | 1644 | 0.080 |
Why?
| Glucose | 2 | 2023 | 896 | 0.080 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2013 | 687 | 0.080 |
Why?
| Pulmonary Fibrosis | 1 | 2011 | 323 | 0.080 |
Why?
| Rats, Sprague-Dawley | 3 | 2018 | 2218 | 0.070 |
Why?
| Biomedical Research | 1 | 2013 | 585 | 0.070 |
Why?
| Curriculum | 1 | 2013 | 819 | 0.070 |
Why?
| Interleukin-1beta | 2 | 2021 | 370 | 0.070 |
Why?
| Diet, Western | 2 | 2018 | 66 | 0.070 |
Why?
| Transcriptional Activation | 1 | 2009 | 337 | 0.070 |
Why?
| Phenotype | 4 | 2018 | 2796 | 0.070 |
Why?
| Polymorphism, Single Nucleotide | 3 | 2021 | 1879 | 0.070 |
Why?
| Pregnancy | 4 | 2021 | 5517 | 0.070 |
Why?
| Heart Failure | 1 | 2019 | 1945 | 0.070 |
Why?
| Disease Susceptibility | 2 | 2019 | 316 | 0.070 |
Why?
| Staphylococcal Infections | 1 | 2011 | 340 | 0.070 |
Why?
| Histocompatibility Antigens Class II | 1 | 2008 | 352 | 0.070 |
Why?
| Interleukin-13 | 2 | 2020 | 122 | 0.070 |
Why?
| Fibroblasts | 1 | 2011 | 838 | 0.070 |
Why?
| Pulmonary Alveoli | 1 | 2009 | 373 | 0.070 |
Why?
| Peptide Fragments | 1 | 2010 | 666 | 0.060 |
Why?
| Lipopolysaccharides | 1 | 2009 | 821 | 0.060 |
Why?
| Child | 5 | 2022 | 18407 | 0.060 |
Why?
| Mice, Inbred BALB C | 2 | 2019 | 1143 | 0.060 |
Why?
| Young Adult | 5 | 2020 | 10465 | 0.060 |
Why?
| Protein Binding | 2 | 2020 | 1889 | 0.060 |
Why?
| Algal Proteins | 1 | 2004 | 4 | 0.060 |
Why?
| Cysteine Endopeptidases | 1 | 2004 | 60 | 0.060 |
Why?
| Cryptochromes | 1 | 2004 | 23 | 0.060 |
Why?
| Multienzyme Complexes | 1 | 2004 | 64 | 0.060 |
Why?
| Antigen-Antibody Reactions | 1 | 2003 | 50 | 0.060 |
Why?
| p38 Mitogen-Activated Protein Kinases | 2 | 2019 | 260 | 0.060 |
Why?
| Oxazoles | 1 | 2003 | 29 | 0.060 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2004 | 133 | 0.050 |
Why?
| Quality Control | 1 | 2023 | 144 | 0.050 |
Why?
| RNA, Small Interfering | 2 | 2018 | 535 | 0.050 |
Why?
| Down-Regulation | 2 | 2020 | 594 | 0.050 |
Why?
| Protoplasts | 1 | 2003 | 7 | 0.050 |
Why?
| Cell Line, Tumor | 2 | 2020 | 2710 | 0.050 |
Why?
| Mutation | 2 | 2004 | 3345 | 0.050 |
Why?
| Introns | 1 | 2004 | 227 | 0.050 |
Why?
| Exons | 1 | 2004 | 302 | 0.050 |
Why?
| Cholesterol, HDL | 1 | 2023 | 183 | 0.050 |
Why?
| Virus Assembly | 1 | 2003 | 67 | 0.050 |
Why?
| Cannabinoid Receptor Modulators | 1 | 2022 | 6 | 0.050 |
Why?
| Polyunsaturated Alkamides | 1 | 2022 | 7 | 0.050 |
Why?
| Microscopy, Electron | 1 | 2003 | 410 | 0.050 |
Why?
| Receptors, Cannabinoid | 1 | 2022 | 13 | 0.050 |
Why?
| Recombinant Proteins | 2 | 2020 | 1230 | 0.050 |
Why?
| Protein Isoforms | 1 | 2004 | 338 | 0.050 |
Why?
| Enzyme Activation | 2 | 2019 | 785 | 0.050 |
Why?
| Seeds | 1 | 2003 | 75 | 0.050 |
Why?
| Receptor, Cannabinoid, CB1 | 1 | 2022 | 28 | 0.050 |
Why?
| Patient Acuity | 1 | 2022 | 42 | 0.050 |
Why?
| Double-Blind Method | 2 | 2018 | 1660 | 0.050 |
Why?
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2022 | 28 | 0.050 |
Why?
| Cholecalciferol | 1 | 2022 | 47 | 0.050 |
Why?
| Diet, Carbohydrate-Restricted | 1 | 2022 | 28 | 0.050 |
Why?
| Adolescent | 4 | 2020 | 17837 | 0.050 |
Why?
| Oxylipins | 1 | 2022 | 27 | 0.050 |
Why?
| Membrane Proteins | 1 | 2008 | 1018 | 0.050 |
Why?
| Inflammation | 2 | 2022 | 2478 | 0.050 |
Why?
| HeLa Cells | 1 | 2003 | 562 | 0.050 |
Why?
| Receptors, Antigen, B-Cell | 1 | 2022 | 107 | 0.050 |
Why?
| Neurons | 2 | 2023 | 1279 | 0.050 |
Why?
| Immunity | 1 | 2022 | 121 | 0.050 |
Why?
| Dietary Carbohydrates | 1 | 2022 | 138 | 0.050 |
Why?
| Longitudinal Studies | 2 | 2022 | 2387 | 0.050 |
Why?
| Nasal Mucosa | 1 | 2022 | 93 | 0.050 |
Why?
| Leptin | 1 | 2022 | 210 | 0.050 |
Why?
| Sex Factors | 2 | 2018 | 1715 | 0.050 |
Why?
| Protein Conformation, beta-Strand | 1 | 2020 | 15 | 0.050 |
Why?
| Sirtuin 2 | 1 | 2020 | 12 | 0.050 |
Why?
| Oxidative Phosphorylation | 1 | 2021 | 155 | 0.050 |
Why?
| Glutamic Acid | 1 | 2022 | 211 | 0.050 |
Why?
| 3T3-L1 Cells | 1 | 2020 | 31 | 0.050 |
Why?
| Minerals | 1 | 2021 | 37 | 0.050 |
Why?
| Cohort Studies | 2 | 2021 | 4895 | 0.050 |
Why?
| Adenosine | 1 | 2022 | 203 | 0.050 |
Why?
| Phosphatidylinositols | 1 | 2020 | 54 | 0.040 |
Why?
| Prescriptions | 1 | 2021 | 60 | 0.040 |
Why?
| Phosphatidylethanolamines | 1 | 2020 | 66 | 0.040 |
Why?
| Molecular Docking Simulation | 1 | 2020 | 101 | 0.040 |
Why?
| Placental Insufficiency | 1 | 2021 | 102 | 0.040 |
Why?
| Metaplasia | 1 | 2020 | 54 | 0.040 |
Why?
| Synaptic Transmission | 1 | 2022 | 227 | 0.040 |
Why?
| Phosphatidylserines | 1 | 2020 | 87 | 0.040 |
Why?
| Receptors, Chemokine | 1 | 2020 | 44 | 0.040 |
Why?
| Adipose Tissue, White | 1 | 2020 | 27 | 0.040 |
Why?
| Triglycerides | 1 | 2022 | 467 | 0.040 |
Why?
| Muscle Fibers, Skeletal | 1 | 2021 | 185 | 0.040 |
Why?
| Calcium Signaling | 2 | 2015 | 217 | 0.040 |
Why?
| Mucus | 1 | 2020 | 54 | 0.040 |
Why?
| Antibodies, Viral | 1 | 2003 | 520 | 0.040 |
Why?
| Interleukin-8 | 1 | 2021 | 237 | 0.040 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2020 | 129 | 0.040 |
Why?
| Water | 1 | 2003 | 396 | 0.040 |
Why?
| Genetic Predisposition to Disease | 2 | 2021 | 2085 | 0.040 |
Why?
| Nutritional Physiological Phenomena | 1 | 2020 | 47 | 0.040 |
Why?
| Pregnancy Trimester, Third | 1 | 2020 | 79 | 0.040 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2020 | 91 | 0.040 |
Why?
| Lipid Bilayers | 1 | 2020 | 99 | 0.040 |
Why?
| Piperidines | 1 | 2021 | 160 | 0.040 |
Why?
| Nutritional Sciences | 1 | 2020 | 37 | 0.040 |
Why?
| Cloning, Molecular | 1 | 2020 | 522 | 0.040 |
Why?
| Cellular Reprogramming | 1 | 2020 | 84 | 0.040 |
Why?
| Genetic Vectors | 1 | 2020 | 289 | 0.040 |
Why?
| Vitamin D | 1 | 2022 | 341 | 0.040 |
Why?
| Ultrasonography, Doppler | 1 | 2020 | 105 | 0.040 |
Why?
| Adaptation, Physiological | 1 | 2003 | 483 | 0.040 |
Why?
| Interferons | 1 | 2020 | 151 | 0.040 |
Why?
| Infant, Small for Gestational Age | 1 | 2020 | 76 | 0.040 |
Why?
| Crystallography, X-Ray | 1 | 2020 | 402 | 0.040 |
Why?
| Sheep | 1 | 2021 | 764 | 0.040 |
Why?
| Biological Transport | 1 | 2020 | 373 | 0.040 |
Why?
| Methylation | 1 | 2019 | 208 | 0.040 |
Why?
| Microglia | 1 | 2021 | 202 | 0.040 |
Why?
| Fibrinogen | 2 | 2010 | 154 | 0.040 |
Why?
| Molecular Dynamics Simulation | 1 | 2020 | 201 | 0.040 |
Why?
| Cilia | 1 | 2020 | 162 | 0.040 |
Why?
| Metagenomics | 1 | 2020 | 131 | 0.040 |
Why?
| Citric Acid Cycle | 1 | 2018 | 43 | 0.040 |
Why?
| Glucose Intolerance | 1 | 2020 | 136 | 0.040 |
Why?
| Molecular Weight | 1 | 2019 | 331 | 0.040 |
Why?
| Animals, Newborn | 1 | 2021 | 778 | 0.040 |
Why?
| Germinal Center | 1 | 2018 | 48 | 0.040 |
Why?
| Lymphocyte Count | 1 | 2018 | 133 | 0.040 |
Why?
| Models, Molecular | 1 | 2003 | 1369 | 0.040 |
Why?
| GTP Phosphohydrolases | 1 | 2018 | 65 | 0.040 |
Why?
| Cyclooxygenase 2 | 1 | 2019 | 164 | 0.040 |
Why?
| Ultrasonography, Prenatal | 1 | 2020 | 236 | 0.040 |
Why?
| Circadian Rhythm | 1 | 2021 | 354 | 0.040 |
Why?
| Predictive Value of Tests | 2 | 2015 | 1796 | 0.040 |
Why?
| Pyridinium Compounds | 1 | 2018 | 13 | 0.040 |
Why?
| Native Polyacrylamide Gel Electrophoresis | 1 | 2018 | 1 | 0.040 |
Why?
| Caspase 1 | 1 | 2018 | 140 | 0.040 |
Why?
| Weight Loss | 1 | 2022 | 642 | 0.040 |
Why?
| Proportional Hazards Models | 1 | 2021 | 1075 | 0.040 |
Why?
| Naphthoquinones | 1 | 2018 | 17 | 0.040 |
Why?
| Fluorescent Antibody Technique | 1 | 2019 | 397 | 0.040 |
Why?
| Methionine | 1 | 2018 | 144 | 0.040 |
Why?
| RNA, Messenger | 2 | 2017 | 2552 | 0.040 |
Why?
| Lysine | 1 | 2019 | 242 | 0.040 |
Why?
| Pregnancy Outcome | 1 | 2020 | 337 | 0.040 |
Why?
| Bone Marrow Cells | 1 | 2018 | 267 | 0.040 |
Why?
| Phospholipase A2 Inhibitors | 1 | 2017 | 3 | 0.040 |
Why?
| Nutritional Status | 1 | 2020 | 287 | 0.040 |
Why?
| Energy Intake | 1 | 2020 | 427 | 0.040 |
Why?
| Fetus | 1 | 2021 | 700 | 0.040 |
Why?
| Pyridines | 1 | 2021 | 425 | 0.040 |
Why?
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 144 | 0.040 |
Why?
| Immunoprecipitation | 1 | 2018 | 151 | 0.040 |
Why?
| RNA-Binding Proteins | 2 | 2011 | 344 | 0.040 |
Why?
| Tissue Donors | 1 | 2019 | 316 | 0.040 |
Why?
| Multivariate Analysis | 1 | 2021 | 1430 | 0.040 |
Why?
| Feces | 1 | 2019 | 373 | 0.040 |
Why?
| Body Mass Index | 2 | 2015 | 1958 | 0.040 |
Why?
| Transfection | 1 | 2019 | 866 | 0.040 |
Why?
| Toll-Like Receptor 9 | 1 | 2017 | 30 | 0.040 |
Why?
| Family | 1 | 2021 | 589 | 0.040 |
Why?
| Gestational Age | 1 | 2020 | 760 | 0.040 |
Why?
| Forensic Medicine | 1 | 2017 | 16 | 0.040 |
Why?
| Pyrrolidines | 1 | 2017 | 55 | 0.040 |
Why?
| Escherichia coli | 1 | 2020 | 720 | 0.030 |
Why?
| Catalytic Domain | 1 | 2018 | 196 | 0.030 |
Why?
| Caloric Restriction | 1 | 2018 | 90 | 0.030 |
Why?
| Gene Knockdown Techniques | 1 | 2018 | 299 | 0.030 |
Why?
| Gene Regulatory Networks | 1 | 2018 | 228 | 0.030 |
Why?
| Influenza A virus | 1 | 2017 | 90 | 0.030 |
Why?
| DNA Damage | 1 | 2019 | 351 | 0.030 |
Why?
| Structure-Activity Relationship | 1 | 2017 | 502 | 0.030 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2021 | 1139 | 0.030 |
Why?
| Methemoglobin | 1 | 2015 | 19 | 0.030 |
Why?
| Placenta | 1 | 2021 | 625 | 0.030 |
Why?
| Child, Preschool | 1 | 2009 | 9111 | 0.030 |
Why?
| Immunoglobulin M | 1 | 2017 | 246 | 0.030 |
Why?
| Prospective Studies | 2 | 2021 | 6217 | 0.030 |
Why?
| Hydrogen Peroxide | 1 | 2017 | 288 | 0.030 |
Why?
| Severity of Illness Index | 2 | 2015 | 2537 | 0.030 |
Why?
| Clone Cells | 1 | 2016 | 247 | 0.030 |
Why?
| Genome-Wide Association Study | 1 | 2021 | 1177 | 0.030 |
Why?
| Etiocholanolone | 1 | 2015 | 7 | 0.030 |
Why?
| Gerbillinae | 1 | 2015 | 61 | 0.030 |
Why?
| Genomics | 1 | 2020 | 635 | 0.030 |
Why?
| Ranolazine | 1 | 2015 | 22 | 0.030 |
Why?
| Trihexosylceramides | 1 | 2015 | 4 | 0.030 |
Why?
| Thiocyanates | 1 | 2015 | 29 | 0.030 |
Why?
| Elasticity | 1 | 2015 | 189 | 0.030 |
Why?
| Pulse Wave Analysis | 1 | 2015 | 207 | 0.030 |
Why?
| Incidence | 1 | 2021 | 2312 | 0.030 |
Why?
| Chronic Disease | 1 | 2020 | 1578 | 0.030 |
Why?
| Mitochondria, Heart | 1 | 2015 | 73 | 0.030 |
Why?
| Immunity, Innate | 1 | 2020 | 720 | 0.030 |
Why?
| Molecular Targeted Therapy | 1 | 2017 | 347 | 0.030 |
Why?
| Host-Pathogen Interactions | 1 | 2017 | 295 | 0.030 |
Why?
| Brachial Artery | 1 | 2015 | 176 | 0.030 |
Why?
| Cardiotonic Agents | 1 | 2015 | 119 | 0.030 |
Why?
| Time Factors | 2 | 2019 | 6115 | 0.030 |
Why?
| Disease Progression | 1 | 2021 | 2380 | 0.030 |
Why?
| Immune Tolerance | 1 | 2016 | 323 | 0.030 |
Why?
| Salmeterol Xinafoate | 1 | 2013 | 41 | 0.030 |
Why?
| Cyclopropanes | 1 | 2013 | 81 | 0.030 |
Why?
| Pregnenolone | 1 | 2013 | 2 | 0.030 |
Why?
| Fluticasone | 1 | 2013 | 87 | 0.030 |
Why?
| Androstadienes | 1 | 2013 | 97 | 0.030 |
Why?
| Albuterol | 1 | 2013 | 102 | 0.030 |
Why?
| Colorado | 1 | 2022 | 4099 | 0.030 |
Why?
| Energy Metabolism | 1 | 2018 | 731 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 1 | 2017 | 1842 | 0.030 |
Why?
| Acetates | 1 | 2013 | 95 | 0.030 |
Why?
| Leukocyte Count | 1 | 2013 | 293 | 0.030 |
Why?
| Sulfides | 1 | 2013 | 94 | 0.030 |
Why?
| Anti-Bacterial Agents | 1 | 2022 | 1481 | 0.030 |
Why?
| Adenosine Triphosphate | 1 | 2015 | 430 | 0.030 |
Why?
| Vasodilation | 1 | 2015 | 419 | 0.030 |
Why?
| Statistics, Nonparametric | 1 | 2013 | 385 | 0.030 |
Why?
| Quinolines | 1 | 2013 | 129 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 313 | 0.030 |
Why?
| Interleukin-4 | 1 | 2013 | 206 | 0.030 |
Why?
| Forced Expiratory Volume | 1 | 2013 | 475 | 0.020 |
Why?
| Interleukin-2 | 1 | 2013 | 413 | 0.020 |
Why?
| Genetic Association Studies | 1 | 2013 | 339 | 0.020 |
Why?
| Mesocricetus | 1 | 2011 | 29 | 0.020 |
Why?
| Eosinophils | 1 | 2013 | 278 | 0.020 |
Why?
| Antioxidants | 1 | 2015 | 530 | 0.020 |
Why?
| Fas Ligand Protein | 1 | 2011 | 57 | 0.020 |
Why?
| Cricetinae | 1 | 2011 | 253 | 0.020 |
Why?
| Cell Line, Transformed | 1 | 2011 | 133 | 0.020 |
Why?
| Myocytes, Cardiac | 1 | 2015 | 449 | 0.020 |
Why?
| Antigen-Presenting Cells | 1 | 2011 | 150 | 0.020 |
Why?
| Regression Analysis | 1 | 2013 | 944 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 797 | 0.020 |
Why?
| Salts | 1 | 2010 | 36 | 0.020 |
Why?
| Cytokines | 1 | 2018 | 1840 | 0.020 |
Why?
| Nitric Oxide | 1 | 2015 | 823 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2020 | 4407 | 0.020 |
Why?
| Spectrophotometry, Ultraviolet | 1 | 2010 | 73 | 0.020 |
Why?
| Fibrin | 1 | 2010 | 65 | 0.020 |
Why?
| Adrenal Cortex Hormones | 1 | 2013 | 497 | 0.020 |
Why?
| HLA-A Antigens | 1 | 2010 | 49 | 0.020 |
Why?
| Surgical Tape | 1 | 2009 | 3 | 0.020 |
Why?
| Endothelin-Converting Enzymes | 1 | 2009 | 10 | 0.020 |
Why?
| Aspartic Acid Endopeptidases | 1 | 2009 | 21 | 0.020 |
Why?
| Interferon-gamma | 1 | 2013 | 719 | 0.020 |
Why?
| Administration, Inhalation | 1 | 2011 | 641 | 0.020 |
Why?
| Thrombin | 1 | 2010 | 139 | 0.020 |
Why?
| Metalloendopeptidases | 1 | 2009 | 55 | 0.020 |
Why?
| alpha-2-HS-Glycoprotein | 1 | 2009 | 2 | 0.020 |
Why?
| Immunoglobulin J-Chains | 1 | 2009 | 6 | 0.020 |
Why?
| Amino Acid Motifs | 1 | 2010 | 197 | 0.020 |
Why?
| Infant, Newborn | 1 | 2020 | 5044 | 0.020 |
Why?
| Pulmonary Surfactant-Associated Protein A | 1 | 2009 | 24 | 0.020 |
Why?
| Mice, Mutant Strains | 1 | 2009 | 271 | 0.020 |
Why?
| Haptoglobins | 1 | 2009 | 47 | 0.020 |
Why?
| Databases, Factual | 1 | 2013 | 1125 | 0.020 |
Why?
| Albumins | 1 | 2009 | 89 | 0.020 |
Why?
| Risk | 1 | 2011 | 812 | 0.020 |
Why?
| Phosphotyrosine | 1 | 2008 | 33 | 0.020 |
Why?
| alpha 1-Antitrypsin | 1 | 2009 | 100 | 0.020 |
Why?
| Endothelin-1 | 1 | 2009 | 167 | 0.020 |
Why?
| Drug Interactions | 1 | 2009 | 338 | 0.020 |
Why?
| src-Family Kinases | 1 | 2008 | 88 | 0.020 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 157 | 0.020 |
Why?
| Protein Conformation | 1 | 2010 | 805 | 0.020 |
Why?
| Staphylococcus aureus | 1 | 2011 | 389 | 0.020 |
Why?
| Lymphoma | 1 | 2008 | 177 | 0.020 |
Why?
| Nanotechnology | 1 | 2008 | 113 | 0.020 |
Why?
| Blood Proteins | 1 | 2009 | 231 | 0.020 |
Why?
| Cell Cycle | 1 | 2009 | 542 | 0.020 |
Why?
| Algorithms | 1 | 2013 | 1467 | 0.020 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2011 | 800 | 0.020 |
Why?
| Age Factors | 1 | 2013 | 2894 | 0.020 |
Why?
| United States | 1 | 2022 | 12179 | 0.020 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 398 | 0.020 |
Why?
| Cell Membrane | 1 | 2009 | 680 | 0.020 |
Why?
| Histones | 1 | 2010 | 535 | 0.020 |
Why?
| Pyrimidines | 1 | 2008 | 376 | 0.020 |
Why?
| Immunoglobulin G | 1 | 2009 | 770 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 2009 | 1131 | 0.020 |
Why?
| Epithelial Cells | 1 | 2010 | 950 | 0.020 |
Why?
| Gene Expression Profiling | 1 | 2011 | 1518 | 0.010 |
Why?
| Tomography, X-Ray Computed | 1 | 2013 | 2285 | 0.010 |
Why?
| Raffinose | 1 | 2003 | 18 | 0.010 |
Why?
| Germination | 1 | 2003 | 5 | 0.010 |
Why?
| T-Lymphocytes | 1 | 2010 | 1737 | 0.010 |
Why?
| Sucrose | 1 | 2003 | 92 | 0.010 |
Why?
| Vaccination | 1 | 2010 | 1204 | 0.010 |
Why?
| Antibodies, Monoclonal | 1 | 2008 | 1262 | 0.010 |
Why?
| Risk Factors | 1 | 2015 | 8631 | 0.010 |
Why?
| Surveys and Questionnaires | 1 | 2011 | 4622 | 0.010 |
Why?
|
|
Reisdorph's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|